These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11720864)

  • 21. Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues.
    Fabbri E; Spisani S; Barbin L; Biondi C; Buzzi M; Traniello S; Zecchini GP; Ferretti ME
    Cell Signal; 2000 Jun; 12(6):391-8. PubMed ID: 10889468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two for-Met-Leu-Phe-OMe analogues trigger selective neutrophil responses. A differential effect on cytosolic free Ca2+.
    Fabbri E; Spisani S; Biondi C; Barbin L; Colamussi ML; Cariani A; Traniello S; Torrini I; Ferretti ME
    Biochim Biophys Acta; 1997 Dec; 1359(3):233-40. PubMed ID: 9434129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains.
    Lucente G; Paradisi MP; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2008 Aug; 35(2):329-38. PubMed ID: 18163179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic formyl tripeptide chemoattractants: a C(alpha,alpha)-dialkylated, amphiphilic glycyl residue at position 1.
    Witkowska R; Zabrocki J; Spisani S; Falzarano MS; Toniolo C; Formaggio F
    J Pept Sci; 2003 Jun; 9(6):354-60. PubMed ID: 12846481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Mastropietro G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1996 Sep; 39(3):327-37. PubMed ID: 8756513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.
    Lucente G; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2009 Jul; 37(2):285-95. PubMed ID: 18636221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides.
    Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Paci M; Sette M; Di Nola A
    Biopolymers; 1993 Mar; 33(3):437-51. PubMed ID: 8461452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotactic peptide analogues. Synthesis and chemotactic activity of N-formyl-Met-Leu-Phe analogues containing (S)-phenylalaninol derivatives.
    Zecchini GP; Paradisi MP; Torrini I; Spisani S
    Arch Pharm (Weinheim); 1995 Sep; 328(9):673-6. PubMed ID: 7487425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing beta-alanine or taurine at the central position.
    Giordano C; Lucente G; Nalli M; Pagani Zecchini G; Paglialunga Paradisi M; Varani K; Spisani S
    Farmaco; 2003 Nov; 58(11):1121-30. PubMed ID: 14572863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Spisani S; Giuliani AL
    Int J Pept Protein Res; 1991 Dec; 38(6):495-504. PubMed ID: 1668096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of (Z)-2,3-didehydrophenylalanine and phenylalanine C-terminal residues in determining the chemotactic activity of formylpeptides.
    Torrini I; Zecchini GP; Paradisi MP; Spisani S
    Arch Pharm (Weinheim); 1996 Mar; 329(3):143-8. PubMed ID: 9005813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1994 Jan; 34(1):1-9. PubMed ID: 8110962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe.
    Giordano C; Lucente G; Masi A; Paglialunga Paradisi M; Sansone A; Spisani S
    Amino Acids; 2007 Sep; 33(3):477-87. PubMed ID: 17021652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.
    Cavicchioni G; Breveglieri A; Boggian M; Vertuani G; Reali E; Spisani S
    J Pept Sci; 1996; 2(3):135-40. PubMed ID: 9231322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An analog of formyl-met-leu-phe effects the movement of human leukocytes].
    Cavalletti T; Spisani S; Gavioli R; Marangoni C; Scatturin A; Vertuani G; Traniello S
    Boll Soc Ital Biol Sper; 1984 Jun; 60(6):1103-9. PubMed ID: 6548144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New fMLF-OMe analogues containing constrained mimics of phenylalanine residue.
    Torrini I; Mastropietro G; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Spisani S
    Arch Pharm (Weinheim); 1998 May; 331(5):170-6. PubMed ID: 9691248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic analogs of chemotactic formylpeptides, I.: Synthesis and biological activity of For-Cys-Leu-Phe-Cys-OMe.
    Zecchini GP; Paradisi MP; Torrini I; Lucente G; Traniello S; Spisani S
    Arch Pharm (Weinheim); 1993 Dec; 326(12):955-8. PubMed ID: 8122965
    [No Abstract]   [Full Text] [Related]  

  • 38. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L; Aksamit RR
    J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formylpeptides trigger selective molecular pathways that are required in the physiological functions of human neutrophils.
    Selvatici R; Falzarano S; Traniello S; Pagani Zecchini G; Spisani S
    Cell Signal; 2003 Apr; 15(4):377-83. PubMed ID: 12618212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe.
    Zecchini GP; Paradisi MP; Torrini I; Nalli M; Lucente G; Spisani S
    Farmaco; 2000 Apr; 55(4):308-13. PubMed ID: 10966163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.